Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ACLS
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 5.53 4.00 3.79
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 11.17 -0.99 -1.11
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.49 27.63 26.44
Cash 4.97 16.24 15.47
Capex 84.01 -0.05 -0.31
Free Cash Flow -26.58 1.24 1.69
Revenue -18.49 7.73 9.49
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 3.47 0.46 0.44
Operating Margin -12.06 0.22 0.25
ROA -28.76 0.04 0.06
ROE -30.36 0.06 0.08
ROIC -25.99 0.05 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ACLS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ACLS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ACLS is permitted for members.